Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 05, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares and American Depositary Receipts (ADRs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction on December 7, 2006, where Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust, transferred 4,500 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of these transactions on March 2, 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are interested in the shares held in the GSK Trust in the same capacity as other employees or former employees. The notification complies with Disclosure Rule 3.1.4R(1)(b).
Investor Verification Points
- Verify the impact of the 4,500 share transfer on the SmithKline Beecham Employee Share Option Plan 1991.
- Confirm the current holdings of the GSK Trust and the specific interests of Directors Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop.
- Note that this filing does not contain financial results; refer to Form 20-F for comprehensive financial data.